Jason Patrick Meyenburg Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Jason Patrick Meyenburg is Chief Executive Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 13,000 shares of GMTX, which is worth approximately $316,810. The most recent transaction as insider was on May 14, 2021, when has been sold 13,000 shares (Common Stock) at a price of $9.46 per share, resulting in proceeds of $122,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13K
0% 3M change
0% 12M change
Total Value Held $316,810

Jason Patrick Meyenburg Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2021
BUY
Open market or private purchase
$122,980 $9.46 p/Share
13,000 Added 50.0%
13,000 Common Stock
JPM

Jason Patrick Meyenburg

Chief Executive Officer
Cambridge,, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX